SANUWAVE Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	44.02	44.05	32.63	20.4	16.74	13.01
Revenue	44.02	44.05	32.63	20.4	16.74	13.01
Revenue Growth	12.67%	34.98%	59.99%	21.84%	28.69%	220.68%
Cost of Revenue	10.42	10.08	8.08	6.04	4.33	4.99
Gross Profit	33.6	33.97	24.55	14.36	12.41	8.02
Selling, General & Admin	27.28	25.22	17.67	13.57	20.03	20.28
Research & Development	2.24	1.35	0.67	0.58	0.57	1.1
Operating Expenses	30.53	27.46	19.13	14.9	21.36	22.17
Operating Income	3.07	6.51	5.42	-0.54	-8.95	-14.14
Interest Expense	-3.46	-6.25	-13.78	-15.62	-14.13	-7.1
Currency Exchange Gain (Loss)	-	-	-	-	-	-0
Other Non Operating Income (Expenses)	12.76	8.87	-31.95	-9.64	16.65	-2.62
EBT Excluding Unusual Items	12.37	9.14	-40.31	-25.8	-6.44	-23.86
Asset Writedown	-0.2	-0.2	-	-	-	-
Other Unusual Items	3.18	2.96	7.26	-	-3.85	-3.37
Pretax Income	15.35	11.9	-33.06	-25.8	-10.29	-27.23
Income Tax Expense	0.09	0.09	0.03	0	0	0.03
Net Income	15.26	11.81	-33.08	-25.81	-10.29	-27.26
Net Income to Common	15.26	11.81	-33.08	-25.81	-10.29	-27.26
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	9	9	4	2	1	1
Shares Outstanding (Diluted)	9	9	4	2	1	1
Shares Change	26.83%	103.51%	110.82%	44.47%	6.00%	37.08%
EPS (Basic)	1.78	1.38	-7.41	-12.19	-7.02	-19.72
EPS (Diluted)	0.78	0.41	-7.41	-12.19	-7.50	-19.72
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	4.21	1.93	1.97	-4.54	-17.17	-6.94
Free Cash Flow Per Share	0.46	0.21	0.44	-2.14	-11.72	-5.02
Gross Margin	76.33%	77.11%	75.23%	70.41%	74.13%	61.68%
Operating Margin	6.97%	14.78%	16.60%	-2.65%	-53.47%	-108.70%
Profit Margin	34.66%	26.82%	-101.38%	-126.52%	-61.48%	-209.52%
Free Cash Flow Margin	9.56%	4.39%	6.02%	-22.25%	-102.55%	-53.33%
EBITDA	4.26	7.49	6.21	0.49	-8	-12.91
EBITDA Margin	9.68%	16.99%	19.01%	2.39%	-47.78%	-99.20%
D&A For EBITDA	1.19	0.97	0.79	1.03	0.95	1.24
EBIT	3.07	6.51	5.42	-0.54	-8.95	-14.14
EBIT Margin	6.97%	14.78%	16.60%	-2.65%	-53.47%	-108.70%
Effective Tax Rate	0.60%	0.72%	-	-	-	-

SEC Filings: 10-K · 10-Q